US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist
  • 88.990
  • +3.440+4.02%
Trading Nov 25 15:37 ET
4.47BMarket Cap36.93P/E (TTM)

Haemonetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Haemonetics Q2 2025 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
342.58M
345.51M
+2.93M
Beat Est.
+7.67%
+8.59%
+0.86%
EPS
0.77
0.66
-0.11
Miss Est.
+60.00%
+37.50%
-14.06%
Analyst Rating
Strong Buy

Nov 25, 2024

Haemonetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 359.056M--
--2025/Q3-- / 353.944M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--
May 9, 20242024/Q4343.290M / 329.468M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 359.056M--
--2025/Q3-- / 353.944M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--
May 9, 20242024/Q4343.290M / 329.468M--

Unlock Free Earnings Estimates

Haemonetics Earnings Reports

  • Haemonetics | 10-Q: Q2 2025 Earnings Report

    Nov 7 06:13 ET

  • Haemonetics | 8-K: Haemonetics Reports Second Quarter and First Half Fiscal 2025 Results; Updates Fiscal 2025 Guidance

    Nov 7 06:09 ET

  • Haemonetics | 10-Q: Q1 2025 Earnings Report

    Aug 8 06:11 ET

  • Haemonetics | 8-K: Haemonetics Reports First Quarter Fiscal 2025 Results; Reaffirms Fiscal 2025 Guidance

    Aug 8 06:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 25, 2024

    Strong Buy

    • Buy

      87.50%

    • Hold

      12.50%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data